{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:08:50Z","timestamp":1792480130979,"version":"4.5.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>The widespread introduction of screening methods allow to identify cervical dysplasia before having invasive cancer. The risk of developing cervical dysplasia persistence\/ recurrence following conization represent a major health issue. Although several studies tried to identify predictors for cervical dysplasia persistence\/recurrence, no previous study has been conducted to develop a risk calculator. The current study aimed to identify predictors of cervical dysplasia persistence\/recurrence among women undergoing primary conization. We aimed to build nomograms estimating the risk of developing cervical dysplasia recurrence. Data of consecutive women with diagnosis of high-risk human papillomavirus (HPV) undergoing conization were retrospectively evaluated (1503 patients). The risk of developing cervical dysplasia persistence\/recurrence was assessed with Kaplan\u2013Meier and Cox\u2019s hazard models. Additionally, two nomograms were built to estimate likelihood of cervical dysplasia recurrence: the first based on baseline and operative parameters and the second focusing on type-specific HPV detected. The performance of the above nomograms was assessed using concordance index. A total of 1503 patients were analyzed. After a mean (SD) follow-up of 48.6 ( \u00b1 17.5) months, 84 (5.6%) patients required secondary conization. By multivariate analysis, HIV infection [hazard ratio (HR): 7.78; 95% confidence interval (CI): 2.77\u201321.81; P &lt; 0.001], positive margins (HR: 26.2; 95% CI: 14.1\u201348.71; P &lt; 0.001) and persistence of HPV (HR: 6.82; 95% CI: 4.15\u201311.21; P &lt; 0.001) correlated with cervical intraepithelial neoplasia 2+ persistence\/recurrence. The importance of those variables was corroborated by our first nomogram. The second nomogram suggested the impact of type-specific HPV infection in predicting cervical dysplasia persistence\/ recurrence. HPV16, HPV18, HPV33, HPV35 and HPV45 were the HPV types most commonly associated with cervical dysplasia persistence\/recurrence. The concordance index was greater than 0.70 for both nomograms, thus suggesting the reproducibility of our models. We developed the first two nomograms predicting this risk. The findings of this study require external validation. Once validated our data might be useful to plan a tailored postoperative surveillance of women receiving primary conization.<\/jats:p>","DOI":"10.1097\/cej.0000000000000475","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T19:10:11Z","timestamp":1543259411000},"page":"435-440","source":"Crossref","is-referenced-by-count":25,"title":["Nomogram-based prediction of cervical dysplasia persistence\/recurrence"],"prefix":"10.1097","volume":"28","author":[{"given":"Giorgio","family":"Bogani","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tagliabue","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ferla","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Ditto","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Chiappa","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Leone Roberti Maggiore","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Taverna","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Transfusion Medicine Service, IRCCS National Cancer Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lombardo","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Transfusion Medicine Service, IRCCS National Cancer Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2015.11.026","article-title":"A pilot study of pNGVL4a-CRT\/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","volume":"140","author":"Alvarez","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2016.12.020","article-title":"Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia.","volume":"210","author":"Bogani","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejogrb.2017.01.057","article-title":"The association of pre-treatment HPV subtypes with recurrence of VIN.","volume":"211","author":"Bogani","year":"2017a","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijgo.12170","article-title":"Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.","volume":"138","author":"Bogani","year":"2017c","journal-title":"Int J Gynecol Obstet"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ygyno.2016.04.015","article-title":"Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.","volume":"141","author":"Cronin","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R8-20230902","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/LGT.0000000000000287","article-title":"Loop electrosurgical excision procedure instead of cold-knife conization for cervical intraepithelial neoplasia in women with unsatisfactory colposcopic examinations: a systematic review and meta-analysis.","volume":"21","author":"El-Nashar","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/ijc.30391","article-title":"Prior human papillomavirus-16\/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: post-hoc analysis from a randomized controlled trial.","volume":"139","author":"Garland","year":"2016","journal-title":"Int J Cancer"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"e79260","DOI":"10.1371\/journal.pone.0079260","article-title":"Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.","volume":"8","author":"Jaisamrarn","year":"2013","journal-title":"PLoS One"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00404-010-1611-1","article-title":"Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women.","volume":"284","author":"Lodi","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3802\/jgo.2016.27.e3","article-title":"Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.","volume":"27","author":"Onuki","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"R14-20230902","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2007.11.009","article-title":"The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence\/recurrence of cervical intraepithelial neoplasia after conization.","volume":"108","author":"Park","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejogrb.2012.06.026","article-title":"Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study.","volume":"165","author":"Serati","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R16-20230902","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2015.01.010","article-title":"Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2","volume":"212","author":"Wilkinson","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20230902","doi-asserted-by":"crossref","first-page":"e0142868","DOI":"10.1371\/journal.pone.0142868","article-title":"Positive surgical margin, HPV persistence, and expression of both TPX2 and PD-L1 are associated with persistence\/recurrence of cervical intraepithelial neoplasia after cervical conization.","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T01:03:15Z","timestamp":1693616595000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000475","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}